Pain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Link
http://link.springer.com/content/pdf/10.1007/s11136-013-0411-z.pdf
Reference50 articles.
1. Lee, D. J., Cha, E. K., Dubin, J. M., Beltran, H., Chromecki, T. F., Fajkovic, H., et al. (2012). Novel therapeutics for the management of castration-resistant prostate cancer (CRPC). BJU International, 109(7), 968–985.
2. de Bono, J. S., Oudard, S., Ozguroglu, M., Hansen, S., Machiels, J.-P., Kocak, I., et al. (2010). Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial. Lancet, 376(9747), 1147–1154.
3. de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., et al. (2011). Abiraterone and increased survival in metastatic prostate cancer. New England Journal of Medicine, 364(21), 1995–2005.
4. Parker, C., Heinrich, D., O’Sullivan, J. M., Fossá, S. D., Chodacki, A., Demkow, T., et al. (2011). Overall survival benefit of radium-223 chloride (alpharadin) in the treatment of patients with symptomatic bone metastases in castration-resistant prostate cancer (CRPC): A phase III randomized trial (ALSYMPCA). [abstract 1LBA]. European Journal of Cancer, 47(suppl 2), 3.
5. Mukherji, D., Pezaro, C. J., & De-Bono, J. S. (2012). MDV3100 for the treatment of prostate cancer. Expert Opinion on Investigational Drugs, 21(2), 227–233.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States;Cancer Research Communications;2024-01-08
2. Comparison of the Novel Digital Multi-dimension Botong Score with the Brief Pain Inventory for Evaluating Cancer-Related Pain: A Randomized Crossover Trial;Pain and Therapy;2023-08-21
3. A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology;Cancers;2022-10-19
4. A randomized controlled trial for acupuncture combined with conventional therapy in the treatment of pain caused by prostate cancer;Medicine;2020-04
5. Assessment of the efficacy of Chinese patent medicine on treating pain caused by prostate cancer;Medicine;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3